Alnylam Pharmaceuticals Inc To Host Investor Call Transcript

Oct 09, 2023 / 12:30PM GMT
Operator

Good day, and thank you for standing by. Welcome to the Alnylam Pharmaceuticals conference call to discuss complete response letter for ONPATTRO (patisiran) supplemental new drug application. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to the company. Please go ahead.

Christine Regan Lindenboom - Alnylam Pharmaceuticals, Inc. - Senior VP of IR & Corporate Communications

Good morning. I'm Christine Lindenboom, Senior Vice President of Investor Relations and Corporate Communications at Alnylam. With me today and available for Q&A are Yvonne Greenstreet, Chief Executive Officer; Pushkal Garg, Chief Medical Officer; Tolga Tanguler, Chief Commercial Officer; Jeff Poulton, Chief Financial Officer; Rena Denoncourt, Vice President, TTR Franchise Lead; and Akshay Vaishnaw, Chief Innovation Officer.

For those of you participating via conference call, the accompanying slides can be accessed by going to the Events section of the Investors page of our website, investors

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot